Zomedica Stock Price

0.0145 (4.08%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 14,297,065
Bid Price
Ask Price
News -
Day High 0.377


52 Week Range


Day Low 0.3553
Company Name Stock Ticker Symbol Market Type
Zomedica Corp ZOM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0145 4.08% 0.3695 19:55:03
Open Price Low Price High Price Close Price Prev Close
0.3658 0.3553 0.377 0.3722 0.355
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
25,999 14,297,065 $ 0.3680635 $ 5,262,228 - 0.175 - 0.80
Last Trade Time Type Quantity Stock Price Currency
20:00:00 12,482 $ 0.3722 USD


Draw Mode:

Zomedica Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 362.07M 979.90M 966.83M $ 4.13M $ - -0.06 -19.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 4.30%

more financials information »

Zomedica News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZOM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.32930.410.32110.365802227,011,9750.040212.21%
1 Month0.2630.410.2440.307415718,365,3720.106540.49%
3 Months0.22710.410.2030.261978521,420,1630.142462.7%
6 Months0.29950.500.1750.284621320,978,5300.0723.37%
1 Year0.4970.800.1750.391963220,790,718-0.1275-25.65%
3 Years0.252.910.06280.758885938,207,2260.119547.8%
5 Years2.352.980.06280.758990424,521,333-1.98-84.28%

Zomedica Description

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now